Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 27 04:00PM ET
4.02
Dollar change
0.00
Percentage change
0.00
%
Index- P/E- EPS (ttm)- Insider Own9.19% Shs Outstand30.46M Perf Week3.88%
Market Cap122.45M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float27.66M Perf Month2.55%
Income- PEG- EPS next Q- Inst Own2.56% Short Float0.08% Perf Quarter9.24%
Sales- P/S- EPS this Y- Inst Trans-52.99% Short Ratio0.46 Perf Half Y74.00%
Book/sh- P/B- EPS next Y- ROA- Short Interest0.02M Perf Year34.00%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range2.08 - 4.03 Perf YTD9.24%
Dividend Est.- P/FCF- EPS past 5Y-13.54% ROI- 52W High-0.25% Beta0.50
Dividend TTM- Quick Ratio- Sales past 5Y30.05% Gross Margin- 52W Low93.25% ATR (14)0.03
Dividend Ex-Date- Current Ratio- EPS Y/Y TTM-115.22% Oper. Margin-118.27% RSI (14)69.87 Volatility1.08% 0.80%
Employees993 Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price4.38
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q-148.15% Payout- Rel Volume1.11 Prev Close4.02
Sales Surprise21.61% EPS Surprise- Sales Q/Q-4.25% Earnings- Avg Volume45.11K Price4.02
SMA202.56% SMA504.23% SMA20022.07% Trades Volume49,808 Change0.00%
Date Action Analyst Rating Change Price Target Change
Jul-14-20Initiated Canaccord Genuity Buy $19
Jul-14-20Initiated BTIG Research Buy $20
Feb-21-24 06:00AM
Jan-17-24 06:05AM
Oct-11-23 04:30PM
May-23-23 04:30PM
Jan-18-23 07:00AM
06:00AM Loading…
Nov-07-22 06:00AM
Oct-12-22 06:00AM
Sep-02-22 07:00AM
Aug-22-22 06:00AM
Aug-19-22 07:18AM
Jun-16-22 09:44AM
Jun-15-22 06:00AM
Jun-02-22 07:20AM
06:00AM
Jun-01-22 06:00AM
04:05PM Loading…
May-23-22 04:05PM
May-03-22 09:11AM
Apr-19-22 06:00AM
Apr-08-22 06:00AM
Apr-07-22 06:00AM
Mar-29-22 07:26AM
Mar-21-22 08:00AM
Mar-09-22 04:05PM
Feb-10-22 03:06AM
Jan-31-22 08:00AM
Jan-10-22 06:00AM
Dec-13-21 01:30AM
Nov-30-21 12:57PM
05:00AM
Nov-29-21 10:00PM
05:00AM Loading…
Nov-16-21 05:00AM
Nov-15-21 08:00AM
05:00AM
Nov-08-21 05:00AM
Nov-04-21 04:05PM
06:00AM
Nov-03-21 02:00AM
Oct-28-21 12:38AM
Oct-23-21 09:45AM
Oct-22-21 07:00AM
Oct-06-21 06:13AM
Sep-27-21 10:25AM
06:00AM
Sep-16-21 06:00AM
Sep-03-21 11:07AM
Aug-30-21 06:00AM
Aug-24-21 07:51AM
07:23AM
Aug-23-21 05:00PM
07:00AM
Aug-11-21 08:00AM
07:21AM
Jul-29-21 04:35AM
Jul-26-21 06:00AM
Jul-13-21 08:30AM
Jul-06-21 04:30AM
Jul-01-21 10:00PM
Jun-04-21 06:00AM
May-24-21 06:45AM
06:00AM
May-20-21 06:16AM
May-13-21 06:20AM
May-10-21 07:00AM
May-03-21 05:00PM
Apr-22-21 06:25PM
Apr-13-21 01:31AM
Apr-01-21 06:00PM
06:39AM
Mar-27-21 04:10AM
Mar-25-21 06:47AM
06:30AM
Mar-24-21 05:00PM
Mar-17-21 04:30PM
Mar-15-21 06:24AM
Mar-04-21 05:00PM
Feb-09-21 07:00AM
Jan-27-21 05:00AM
Jan-13-21 06:30AM
Jan-07-21 09:32AM
08:20AM
Jan-06-21 04:40AM
Dec-20-20 03:04AM
Dec-11-20 10:38PM
Nov-27-20 08:00AM
Nov-20-20 06:00AM
Nov-19-20 09:53AM
Nov-12-20 05:30AM
Nov-09-20 06:30AM
06:30AM
Oct-29-20 08:00AM
Oct-26-20 08:00AM
Oct-22-20 06:00AM
Sep-30-20 08:11AM
Sep-25-20 06:00AM
Sep-18-20 06:00AM
Sep-08-20 04:15PM
Aug-29-20 10:32AM
Aug-06-20 06:30AM
Jul-29-20 04:39PM
Jul-27-20 04:30PM
Genetron Holdings, Ltd. engages in precision oncology. It provides cancer molecular profiling by using technologies in molecular biology and data science to transform cancer treatment. It products and services include diagnosis and monitoring through both LDT and IVD products. Its LDT portfolio consists of both specifically designed focused and comprehensive gene panel testing services. It also develops liver cancer early screening products. The company was founded by Si Zhen Wang, Hai Yan, and Wei Wu He in 2015 and is headquartered in Beijing, China.